Strabismus surgery outcomes for internuclear ophthalmoplegia with exotropia
- 3 April 2022
- journal article
- research article
- Published by Taylor & Francis Ltd in Strabismus
- Vol. 30 (2), 65-71
- https://doi.org/10.1080/09273972.2022.2061528
Abstract
Exotropia (XT) in internuclear ophthalmoplegia (INO) is a difficult problem to treat. The purpose of this study is to describe surgical approaches in treating INO and glean insight into various pre-operative factors that may affect outcomes for XT in INO. We conducted a retrospective review from 1 January 1995 – 5 January 2021 and identified seven patients with INO who underwent strabismus surgery for XT. Patient age, sex, etiology of INO, pre-operative alignment and sensorimotor exam, presence of diplopia, surgery performed, subsequent surgeries, use of adjustable sutures, post-operative alignment, presence of post-operative diplopia, presence of post-operative diplopia with use of prism correction, and length of follow-up were all collected. Initial surgeries undertaken included unilateral medial rectus (MR) plication and lateral rectus (LR) recession, bilateral medial rectus (MR) plications or resections, or bilateral MR plications combined with either unilateral or bilateral LR recessions. Chart review yielded ten charts, however two were excluded due to manifest esotropia (ET), and one was excluded due to incomplete records. Seven total patients were used in final analysis. The cohort age range was from 29 to 79 years. Pre-operative horizontal distance alignment ranged from 35 to 95 XT with an average exodeviation of 67.8 ± 22.6 prism diopters (PD). Horizontal adduction deficit ranged from −1 to −4 and was present bilaterally in all patients. A variety of initial surgical approaches were undertaken. After two muscle surgeries, distance deviation had an average change of 57.3 PD. After three muscle surgeries, distance deviation had an average change of 75 PD. After four muscle surgeries, distance deviation had an average change of 60 PD. Three patients required additional surgery for XT. Time to follow-up ranged from 1 to 58 months. Horizontal distance alignment in primary gaze at latest follow-up ranged from 30 ET to 30 XT with an average of 0 (orthotropia) ± 16.0 PD. One patient had a consecutive esotropia of 30 PD, one had a persistent exotropia of 30 PD, and five patients were orthotropic at distance. All patients reported relief of diplopia in primary gaze at near and distance either with or without use of prism. Horizontal ductions improved to some degree in all patients. Horizontal rectus surgery can treat many cases of XT in INO. Surgeons should consider INO etiology and concomitant vertical deviations when considering surgery. The degree of pre-operative adduction limitation is another important factor, though did not always dictate final motor and sensory outcomes.Keywords
Funding Information
- National Institutes of Health
- National Eye Institute (P30-EY06360)
- Emory University School of Medicine
This publication has 11 references indexed in Scilit:
- Compartmental StrabismusJournal of Binocular Vision and Ocular Motility, 2020
- Transposition surgery for WEBINOInternational Ophthalmology, 2016
- Wall‐eyed bilateral internuclear ophthalmoplegia: review of pathogenesis, diagnosis, prognosis and managementClinical and Experimental Optometry, 2015
- Transposition Surgery for Internuclear OphthalmoplegiaJournal of Pediatric Ophthalmology & Strabismus, 2012
- Strabismus surgery for internuclear ophthalmoplegia with exotropia in multiple sclerosisJournal of American Association for Pediatric Ophthalmology and Strabismus, 2009
- Results of extraocular muscle surgery in WEBINO bilateral internuclear ophthalmoplegia patientsJournal of American Association for Pediatric Ophthalmology and Strabismus, 2008
- Botulinum toxin in the management of internuclear ophthalmoplegiaJournal of American Association for Pediatric Ophthalmology and Strabismus, 2007
- Active management of exotropia due to brainstem diseaseNeuro-Ophthalmology, 2002
- Surgical treatment of supranuclear and internuclear ocular motility disordersEye, 1997
- Botulinum Toxin Injection in the Management of Lateral Rectus ParesisOphthalmology, 1985